Bone marrow clues may explain why half of 'good prognosis' leukemia patients relapse

This study looked at bone marrow cells from 70 adults with a favorable type of acute myeloid leukemia (AML) that has a mutation in the NPM1 gene. Even though these patients are expected to do well with standard treatment, more than half still relapse. Researchers wanted to see if the behavior of certain bone marrow support cells (mesenchymal stem cells) could help explain why. The goal was to find new markers that might predict patient outcomes better than current methods.